# Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)

> **NCT00202891** · PHASE4 · WITHDRAWN · sponsor: **Merck Sharp & Dohme LLC**

## Conditions studied

- Pyoderma

## Interventions

- **DRUG:** sisomicin

## Key facts

- **NCT ID:** NCT00202891
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-05
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No further local interest in pursuing the study.
- **Last updated:** 2015-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00202891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00202891, "Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00202891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*